Home › Oropharyngeal Cancer › Michigan › Ann Arbor
Oropharyngeal Cancer clinical trials in Ann Arbor, MI
4 studies for Oropharyngeal Cancer are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RecruitingPhase 2
- University of Michigan Rogel Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi away
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi away
- and 5 more
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
RecruitingPhase 3
- University of Michigan Rogel Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi away
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
RecruitingPhase 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Oropharyngeal Cancer trials in other cities
- Atlanta, GA8 studies
- Edison, NJ8 studies
- Chicago, IL7 studies
- New York City, NY6 studies
- Queens, NY5 studies
- St. Louis, MO5 studies
- Kansas City, MO5 studies
- Tampa, FL5 studies
- Pittsburgh, PA5 studies
- Philadelphia, PA5 studies
- Omaha, NE5 studies
- Milwaukee, WI5 studies
Other studies in Ann Arbor
- Breast Cancer27 studies
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Stroke12 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.